Fall Intensive Topics 2019

Pain Psychology: What You and Your Patients Need to Know

Dr. Geralyn Datz

– Attendees will be able to describe the impact of chronic pain as a public  health problem

Attendees will learn how to assess for the impact of chronic pain on a patient’s mental health

– Attendees will be educated how and when to refer patients for pain psychology and what this treatment entails

– Attendees will understand how to apply cognitive behavioral principals to the treatment and management of chronic pain

 

Pain Management & Opioids: Balancing Risks and Benefits

Dr. Karen Muchowski

– Describe the pathophysiology of pain as it relates to the concepts of pain management

– Accurately assess patients in pain

– Develop a safe and effective pain treatment plan

– Identify evidence-based non-opioid options for the treatment of pain

– Identify the risks and benefits of opioid therapy

– Manage ongoing opioid therapy

– Recognize behaviors that may be associated with opioid use disorder

 

Management of Osteoarthritis & Back Pain

Dr. Jeffrey A. Zlotnick, Family Physician, Reading, PA

– Recognize the pathophysiologic mechanisms of chronic pain

– Describe the various clinical presentations of chronic pain

– Diagnose and manage chronic pain in osteoarthritis and low back pain

– Develop individualized, evidence-based treatment plans for chronic pain

– Discuss the latest clinical data on novel analgesic targets

 

The Department of Justice and the Opioid Crisis!

John Meynardie

– Explain the origin and depths of the opioid epidemic, including what’s continuing to fuel the crisis

– Explain the Department of Justice’s approach to the crisis that includes prevention, enforcement and treatment

– Explain the basis for federal prosecution under the Controlled Substance Act.

 

Documentation for Opioid Prescribing

Kathy Stone

– Recommendations for information that should be included in the medical record when prescribing scheduled drugs

– Discussion of MS State Board of Medical Licensure position

– Discussion of CDC guidelines and DEA requirements